Terms: = Pancreatic cancer AND ENO2, HEL-S-279, NSE AND Treatment
24 results:
1. High-Fat Mouse Model to Explore the Relationship between Abnormal Lipid Metabolism and Enolase in pancreatic cancer.
Qin L; Sun K; Shi L; Xu Y; Zhang R
Mediators Inflamm; 2023; 2023():4965223. PubMed ID: 37731842
[TBL] [Abstract] [Full Text] [Related]
2. EMT Molecular Signatures of pancreatic Neuroendocrine Neoplasms.
Venugopal A; Michalczyk A; Khasraw M; Ackland ML
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362433
[TBL] [Abstract] [Full Text] [Related]
3. An EGFR-mutant lung adenocarcinoma that transformed into small-cell lung cancer. A case report.
Chowaniecova G; Berzinec P; Kosturiakova G; Plank L; Farkasova A; Sekeresova M; Juskanic D; Ondrus D
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2022 Dec; 166(4):451-454. PubMed ID: 36036563
[TBL] [Abstract] [Full Text] [Related]
4. [Comparison of clinical features between sporadic pancreatic neuroendocrine tumors and those associated with multiple endocrine neoplasia type 1].
Gu DY; Fu Q; Xue BY; Kan JB; Bai JA; Tang QY
Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(14):1014-1019. PubMed ID: 35399021
[No Abstract] [Full Text] [Related]
5. Serum Biomarker Status with a Distinctive Pattern in Prognosis of Gastroenteropancreatic Neuroendocrine Carcinoma.
Zhang J; Cao Y; Zhang P; Zhang X; Li J; Zhou J; Wang X; Peng Z; Sun Y; Li J; Shen L; Lu M
Neuroendocrinology; 2022; 112(8):733-743. PubMed ID: 34592743
[TBL] [Abstract] [Full Text] [Related]
6. Two case reports of brain metastases in patients with pancreatobiliary neuroendocrine carcinoma.
Furukawa T; Sasaki T; Takeda T; Mie T; Kanata R; Kasuga A; Matsuyama M; Ozaka M; Sasahira N
Clin J Gastroenterol; 2021 Feb; 14(1):386-390. PubMed ID: 33095423
[TBL] [Abstract] [Full Text] [Related]
7. A case report of rare ectopic pheochromocytoma adjacent to pancreas.
Jiang C; Zhao J; Sun L; Cai B
Medicine (Baltimore); 2020 Jun; 99(25):e20858. PubMed ID: 32569235
[TBL] [Abstract] [Full Text] [Related]
8. The Feasibility of Serum Multiple Tumor Markers Test Between Patients with Primary pancreatic cancer and Those with Benign pancreatic Cystic Disease.
Lee JH
Clin Lab; 2019 Oct; 65(10):. PubMed ID: 31625360
[TBL] [Abstract] [Full Text] [Related]
9. First reported case of a collision tumor composed of pancreatic adenocarcinoma and retroperitoneal liposarcoma: a case report.
Buchner D; Hieggelke L; Löser H; Bruns CJ; Quaas A; Ghadimi MPH
BMC Cancer; 2018 Dec; 18(1):1243. PubMed ID: 30541485
[TBL] [Abstract] [Full Text] [Related]
10. Neuroendocrine Breast Carcinomas Share Prognostic Factors with Gastroenteropancreatic Neuroendocrine Tumors: A Putative Prognostic Role of Menin, p27, and SSTR-2A.
Roininen N; Takala S; Haapasaari KM; Jukkola-Vuorinen A; Mattson J; Heikkilä P; Karihtala P
Oncology; 2019; 96(3):147-155. PubMed ID: 30282082
[TBL] [Abstract] [Full Text] [Related]
11. Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort.
Walter T; Tougeron D; Baudin E; Le Malicot K; Lecomte T; Malka D; Hentic O; Manfredi S; Bonnet I; Guimbaud R; Coriat R; Lepère C; Desauw C; Thirot-Bidault A; Dahan L; Roquin G; Aparicio T; Legoux JL; Lombard-Bohas C; Scoazec JY; Lepage C; Cadiot G;
Eur J Cancer; 2017 Jul; 79():158-165. PubMed ID: 28501762
[TBL] [Abstract] [Full Text] [Related]
12. [Advances of circulating biomarkers in gastroenteropancreatic neuroendocrine neoplasms].
Chen L; Chen M; Chen J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Mar; 20(3):357-360. PubMed ID: 28338171
[TBL] [Abstract] [Full Text] [Related]
13. Outcome of peptide receptor radionuclide therapy with 177Lu-octreotate in advanced grade 1/2 pancreatic neuroendocrine tumours.
Ezziddin S; Khalaf F; Vanezi M; Haslerud T; Mayer K; Al Zreiqat A; Willinek W; Biersack HJ; Sabet A
Eur J Nucl Med Mol Imaging; 2014 May; 41(5):925-33. PubMed ID: 24504504
[TBL] [Abstract] [Full Text] [Related]
14. Neuroendocrine phenotype alteration and growth suppression through apoptosis by MK-2206, an allosteric inhibitor of AKT, in carcinoid cell lines in vitro.
Somnay Y; Simon K; Harrison AD; Kunnimalaiyaan S; Chen H; Kunnimalaiyaan M
Anticancer Drugs; 2013 Jan; 24(1):66-72. PubMed ID: 23147412
[TBL] [Abstract] [Full Text] [Related]
15. Primary neuroendocrine carcinoma of the kidney.
Dvorackova J; Macak J; Brzula P; Tomanova R; Dokulil J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Sep; 157(3):257-60. PubMed ID: 23073523
[TBL] [Abstract] [Full Text] [Related]
16. Chromogranin A and neuron-specific enolase as prognostic markers in patients with advanced pNET treated with everolimus.
Yao JC; Pavel M; Phan AT; Kulke MH; Hoosen S; St Peter J; Cherfi A; Öberg KE
J Clin Endocrinol Metab; 2011 Dec; 96(12):3741-9. PubMed ID: 21994954
[TBL] [Abstract] [Full Text] [Related]
17. Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial.
Yao JC; Lombard-Bohas C; Baudin E; Kvols LK; Rougier P; Ruszniewski P; Hoosen S; St Peter J; Haas T; Lebwohl D; Van Cutsem E; Kulke MH; Hobday TJ; O'Dorisio TM; Shah MH; Cadiot G; Luppi G; Posey JA; Wiedenmann B
J Clin Oncol; 2010 Jan; 28(1):69-76. PubMed ID: 19933912
[TBL] [Abstract] [Full Text] [Related]
18. [Combined small-cell carcinoma/adenocarcinoma of prostate: report of two cases].
Sakuma T; Yoshida T; Ohashi H; Nishimura K; Kawano K
Hinyokika Kiyo; 2007 Jul; 53(7):489-92. PubMed ID: 17702184
[TBL] [Abstract] [Full Text] [Related]
19. Clear cell carcinoid tumor of the distal common bile duct.
Todoroki T; Sano T; Yamada S; Hirahara N; Toda N; Tsukada K; Motojima R; Motojima T
World J Surg Oncol; 2007 Jan; 5():6. PubMed ID: 17227590
[TBL] [Abstract] [Full Text] [Related]
20. [A case of pancreatic ductal adenocarcinoma with rapid progress in a young man].
Yasuda M; Senju T; Aratake Y; Nakamura T; Horikawa Y; Yokota M; Sumii T; Iguchi H; Funakoshi A; Nishiyama K
Nihon Shokakibyo Gakkai Zasshi; 2006 Feb; 103(2):194-9. PubMed ID: 16506669
[TBL] [Abstract] [Full Text] [Related]
[Next]
